Liver Function-Related Indicators and Risk of Gallstone Diseases-A Multicenter Study and a Systematic Review and Meta-Analysis
- PMID: 39220730
- PMCID: PMC11366059
- DOI: 10.1155/2024/9097892
Liver Function-Related Indicators and Risk of Gallstone Diseases-A Multicenter Study and a Systematic Review and Meta-Analysis
Abstract
Purpose of the study: We aim to examine the association between liver function-related indicators and gallstone disease (GSD) risk. Study design: The subjects who participated in the China Multicenter Physical Examination Cohort (CMPEC) were enrolled. Relative odds ratios (ORs) with 95% CIs and standardized mean differences (SMDs) were applied to investigate the effect of liver function-related indicators and GSD risk. Moreover, a systematic review and meta-analysis were conducted until July 2021. Additionally, the results in the CMPEC and the systematic review and meta-analysis were combined by meta-analysis. Finally, the results were validated by a cohort study of the UK Biobank (UKB). Results and conclusions: Totally, 369,931 subjects in CMPEC were included in the study. A total of 28 publications were incorporated into the systematic review and meta-analysis. The pooled analysis suggested that aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), total protein (TP), and low albumin (ALB) were positively associated with the risk of GSD. Meanwhile, GSD present to have higher AST, ALT, gamma-glutamyl transferase (GGT), total bilirubin (TBil), globulin (G), and ALP levels and relatively lower TP and ALB levels than the healthy participants. These results were consistent when stratified by the study design, geographic background, and study quality. Only the association between ALP and GSD risk was validated in the UKB cohort. This study suggests liver function indicators were associated with GSD risk. The results may provide the basis for exploring the etiology of GSD and may help clinicians identify high-risk subjects. Trial Registration: PROSPERO (CRD42020179076).
Keywords: gallstone disease; liver function-related indicators; multicenter cross-sectional study; systematic review and meta-analysis.
Copyright © 2024 Shiyi Li et al.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Circulating liver function markers and the risk of COPD in the UK Biobank.Front Endocrinol (Lausanne). 2023 Mar 22;14:1121900. doi: 10.3389/fendo.2023.1121900. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37033218 Free PMC article.
-
Bidirectional associations among gallstone disease, non-alcoholic fatty liver disease, kidney stone disease.World J Gastroenterol. 2024 Dec 14;30(46):4914-4928. doi: 10.3748/wjg.v30.i46.4914. World J Gastroenterol. 2024. PMID: 39679314 Free PMC article.
-
Associations between organophosphate esters concentrations and markers of liver function in US adolescents aged 12-19 years: A mixture analysis.Environ Pollut. 2022 Dec 1;314:120255. doi: 10.1016/j.envpol.2022.120255. Epub 2022 Sep 22. Environ Pollut. 2022. PMID: 36155224
-
[Dynamic change study of dermatitis medicamentosa-like of trichloroethylene patients with liver damage].Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2011 Oct;29(10):790-3. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2011. PMID: 22468317 Chinese.
-
Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.Hepatol Int. 2020 Sep;14(5):621-637. doi: 10.1007/s12072-020-10074-6. Epub 2020 Jul 24. Hepatol Int. 2020. PMID: 32710250 Free PMC article.
Cited by
-
Factors influencing the cure of pseudolithiasis: a retrospective study of 264 patients.BMC Gastroenterol. 2025 Feb 22;25(1):105. doi: 10.1186/s12876-025-03704-6. BMC Gastroenterol. 2025. PMID: 39987035 Free PMC article.
References
-
- Zhuang X., Li U. Epidemiologic study of risk factors of gallstone. Zhonghua Liu Xing Bing Xue Za Zhi . 1999;20(3):181–183. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous